ProPhase Labs, Inc. Competitors

PRPH 
$1.32
*  
unch
unch
Get PRPH Alerts
*Delayed - data as of Mar. 3, 2015 10:59 ET  -  Find a broker to begin trading PRPH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PRPH Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

ProPhase Labs, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume ▼ Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Oncolytics Biotech, Inc.
ONCY: NASDAQ-CM
$ 1.13 0.06 ▲ 22,680,473 $ 1.40
$ 1.12
$ 2.07
$ .40
NE 95,828,520
Orexigen Therapeutics, Inc.
OREX: NASDAQ-GS
$ 7.935 2.15 ▲ 18,401,178 $ 7.98
$ 5.92
$ 7.82
$ 3.11
NE 977,322,210
MannKind Corporation
MNKD: NASDAQ-GM
$ 6.01 -0.63 ▼ 11,709,187 $ 6.23
$ 5.74
$ 11.48
$ 3.80
NE 2,438,257,000
Pfizer, Inc.
PFE: NYSE
$ 34.62 -0.15 ▼ 6,504,452 $ 34.89
$ 34.41
$ 34.97
$ 27.51
24.38 212,180,960,100
Arena Pharmaceuticals, Inc.
ARNA: NASDAQ-GS
$ 4.0601 -0.22 ▼ 4,021,311 $ 4.20
$ 3.85
$ 7.24
$ 3.26
NE 893,688,912
Celgene Corporation
CELG: NASDAQ-GS
$ 117.4096 -2.90 ▼ 3,091,254 $ 120.19
$ 116.34
$ 125.45
$ 66.85
48.92 93,775,517,158
AEterna Zentaris Inc.
AEZS: NASDAQ-CM
$ .7795 0.14 ▲ 2,985,236 $ .795
$ .65
$ 1.54
$ .48
NE 44,052,663
Akorn, Inc.
AKRX: NASDAQ-GS
$ 49.005 -4.71 ▼ 2,480,731 $ 51.90
$ 48.17
$ 55.86
$ 20.52
148.5 5,284,258,155
Merck & Company, Inc.
MRK: NYSE
$ 58.01 -0.57 ▼ 2,059,833 $ 58.70
$ 58.01
$ 63.62
$ 52.49
14.15 164,643,575,930
Mylan N.V.
MYL: NASDAQ-GS
$ 56.28 -1.61 ▼ 1,990,444 $ 57.20
$ 55.90
$ 59.60
$ 44.74
NE 21,064,140,720
VIVUS, Inc.
VVUS: NASDAQ-GS
$ 2.8948 0.12 ▲ 1,964,050 $ 2.90
$ 2.6901
$ 6.40
$ 2.41
NE 300,127,074
AbbVie Inc.
ABBV: NYSE
$ 60.29 -0.17 ▼ 1,833,614 $ 60.45
$ 59.58
$ 70.76
$ 45.50
55.31 96,095,447,230
Johnson & Johnson
JNJ: NYSE
$ 102.44 -0.78 ▼ 1,664,730 $ 103.10
$ 102.3201
$ 109.49
$ 90.83
17.97 284,833,293,160
Opko Health Inc
OPK: NYSE
$ 13.97 -0.47 ▼ 1,595,099 $ 14.19
$ 13.92
$ 15.23
$ 7.82
NE 6,309,229,190
Cyclacel Pharmaceuticals, Inc.
CYCC: NASDAQ-GM
$ 1.52 -0.17 ▼ 1,379,752 $ 1.58
$ 1.46
$ 4.14
$ .511
NE 34,923,520
KaloBios Pharmaceuticals, Inc.
KBIO: NASDAQ-GM
$ .60 0.01 ▲ 1,295,501 $ .63
$ .56
$ 3.69
$ .3621
NE 19,792,800
GlaxoSmithKline PLC
GSK: NYSE
$ 47.92 -0.01 ▼ 1,271,176 $ 48.11
$ 47.88
$ 56.60
$ 41.25
26.19 20,649,398,880
Salix Pharmaceuticals, Ltd.
SLXP: NASDAQ-GS
$ 156.73 -0.15 ▼ 1,246,593 $ 156.85
$ 156.52
$ 172.98
$ 86
NE 9,987,305,790
Achillion Pharmaceuticals, Inc.
ACHN: NASDAQ-GS
$ 11.99 -0.36 ▼ 1,158,398 $ 12.35
$ 11.75
$ 16.87
$ 2.45
NE 1,367,423,530
Abbott Laboratories
ABT: NYSE
$ 47.02 -0.20 ▼ 1,098,059 $ 47.14
$ 46.77
$ 47.88
$ 36.65
31.56 70,952,145,560
Synergy Pharmaceuticals, Inc.
SGYP: NASDAQ-GS
$ 3.4466 0.13 ▲ 1,031,308 $ 3.50
$ 3.34
$ 6.70
$ 2.45
NE 332,976,026
Bristol-Myers Squibb Company
BMY: NYSE
$ 61.84 -0.46 ▼ 1,001,442 $ 62.25
$ 61.34
$ 64.44
$ 46.30
51.53 102,785,377,120
Durect Corporation
DRRX: NASDAQ-GM
$ 1.21 0.18 ▲ 998,904 $ 1.32
$ 1.06
$ 1.89
$ .68
NE 137,547,960
Endo International plc
ENDP: NASDAQ-GS
$ 86.30 -1.02 ▼ 939,077 $ 87.19
$ 86.076
$ 89.88
$ 53.62
NE 14,904,786,700
Array BioPharma Inc.
ARRY: NASDAQ-GM
$ 8.04 -0.16 ▼ 894,883 $ 8.30
$ 8
$ 8.55
$ 2.98
NE 1,060,982,520